Key facts
- JuneBrain’s last known valuation is $9.9M (Feb 2026).
- It has raised $1.9M across 2 recorded rounds; the latest was Seed Round ($450K) in Sep 2025.
- Notable investors include US National Science Foundation, MedTech Innovator, Springboard Enterprises, TEDCO, Innovation Works — 20 tracked in total.
- JuneBrain has filed 2 Form Ds with the SEC since 2023, most recently Oct 2025 ($450K sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for JuneBrain
Funding rounds
2 roundsAbout JuneBrain
Developer of a retinal imaging system designed to optimize remote assessment and monitoring of neurological diseases. The company's system offers wearable and non-invasive imaging devices that detect attacks and improve monitoring of treatment efficacy, enabling clinicians to monitor patients with eye and brain diseases outside of the traditional clinic setting.
- Industry
- Monitoring Equipment
- Sector
- Healthcare
- HQ
- Baltimore, MD, United States
- Founded
- 2017
- Employees
- 10
- Website
- junebrain.com/
- Ownership
- Privately Held (backing)
JuneBrain doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in JuneBrain shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on JuneBrain in its N-PORT filings yet. We sweep new filings monthly.